THC
61
3
NRG
57
2
MA
65
-4
EXC
50
-4
TJX
50
2
TGT
50
2
TGNA
51
3
QRVO
33
-3
ECL
69
-3
SYY
50
-8
WU
16
2
EMN
70
-2
STZ
54
-4
D
55
-6
HES
59
3
CNX
76
5
ADP
70
-3
MNST
52
2
ORLY
64
2
LB
41
-11
THC
61
3
NRG
57
2
MA
65
-4
EXC
50
-4
TJX
50
2
TGT
50
2
TGNA
51
3
QRVO
33
-3
ECL
69
-3
SYY
50
-8
WU
16
2
EMN
70
-2
STZ
54
-4
D
55
-6
HES
59
3
CNX
76
5
ADP
70
-3
MNST
52
2
ORLY
64
2
LB
41
-11
Financhill
Back

Biodexa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options
Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
0.38
Seasonality Move:
-44.32%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Biodexa Pharmaceuticals PLC Price Quote

$0.38
+0.01 (+1.99%)
(Updated: September 19, 2024 at 12:45 PM ET)

Biodexa Pharmaceuticals PLC Key Stats

Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell
Day range:
$0.37 - $0.39
52-week range:
$0.35 - $8.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.17
P/B ratio:
0.91%
Volume:
146.3K
Avg. volume:
171K
1-year change:
-93.56%
Market cap:
$5.4M
Revenue:
$474.1K
EPS:
$-402

How Much Does Biodexa Pharmaceuticals PLC Make?

Is Biodexa Pharmaceuticals PLC Growing As A Company?

Data Unavailable

Biodexa Pharmaceuticals PLC Stock Price Performance

What Is Biodexa Pharmaceuticals PLC 52-Week High & Low?

Biodexa Pharmaceuticals PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biodexa Pharmaceuticals PLC?

Is Biodexa Pharmaceuticals PLC Cash Flow Positive?

  • What Is BDRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.5M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.8M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$328.9K

Biodexa Pharmaceuticals PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    BDRX return on invested capital is -160.77%
  • What Is Biodexa Pharmaceuticals PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -87.8%
  • What Is BDRX Return On Equity?
    ROE is a measure of profitability and is -160.77%

Biodexa Pharmaceuticals PLC Earnings Date & Stock Price

Biodexa Pharmaceuticals PLC Competitors

Biodexa Pharmaceuticals PLC Dividend Yield

Biodexa Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.02
Upside from Last Price: 2051.16%

Major Shareholders

  • How many BDRX shares are owned by institutional investors?
    178.4K BDRX shares are owned by institutional investors
  • How many BDRX shares are owned by insiders?
    1.3M BDRX shares are owned by insiders